Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections
Open accessAbstract
Vulvovaginal candidiasis (VVC) is a prevalent infection of the genitourinary tract affecting millions of women worldwide. In the present study, the importance of virulence factors, ERG11 gene mutations, ERG11 gene expression, and plasma membrane ergosterol content for fluconazole resistance in Candida species was investigated in 200 women suspected of vulvovaginitis. Isolated Candida species were identified using the ITS-restriction fragment length polymorphism (ITS-RFLP) technique. Antifungal susceptibility testing was performed according to the CLSI document. ERG11 gene expression was analyzed using real-time PCR. ERG11 gene mutation analysis was performed using sequencing methods, and the ergosterol content of the cell membrane was determined in fluconazole-resistant isolates. Furthermore, the production of phospholipase and proteinase enzymes was evaluated in recurrent and non-recurrent infections. VVC was diagnosed in 101 (50.5%) of the 200 clinical cases, of which 21 (20.8%) were confirmed as RVVC. Candida albicans was the most prevalent species, followed by C. glabrata, C. tropicalis, C. krusei, C. parapsilosis, and C. guilliermondii. Ketoconazole and fluconazole were the most effective drugs against C. albicans among five tested antifungals with MIC ranges between 0.06 and 16 μg/mL and 0.25-64 μg/mL. Substitutions of A114S, Y257H, T123I and A114V were detected in fluconazole-resistant C. albicans. The ergosterol content of the fungal cell membrane and the mean levels of ERG11 gene expression transcript were higher in fluconazole-resistant C. albicans isolates obtained from RVVC than in those obtained from VVC cases. Phospholipase and proteinase were produced in different amounts in all Candida species isolated from VVC and RVVC cases. In this review, our results demonstrated that several molecular mechanisms, including ERG11 gene expression, changes in the cell membrane ergosterol content, and mutations in ERG11 gene alone or simultaneously involved in fluconazole resistance of C. albicans species and the recurrence of VVC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · see citing works
Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics
White, T. J., Bruns, T., Lee, S., & Taylor, J. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50042-1 · Cited by 36,648 · see citing works
MEGA2: molecular evolutionary genetics analysis software
Kumar, S., Tamura, K., Jakobsen, I. B., & Nei, M. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1244 · Cited by 6,046 · see citing works
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · see citing works
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works
<i>Candida albicans</i> pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848 · see citing works
Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270 · see citing works
Potential Role of Phospholipases in Virulence and Fungal Pathogenesis
Ghannoum, M. A. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.122-143.2000 · Cited by 814 · see citing works
Plate method for detection of phospholipase activity inCandida albicans
Price, M. F., Wilkinson, I. D., & Gentry, L. O. (1982) · Medical Mycology · doi:10.1080/00362178285380031 · Cited by 651 · see citing works
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647 · see citing works
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639 · see citing works
A One-Enzyme PCR-RFLP Assay for Identification of Six Medically Important Candida Species
Mirhendi, H., Makimura, K., Khoramizadeh, M., & Yamaguchi, H. (2006) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.47.225 · Cited by 246 · see citing works
Serum-proteins as nitrogen source for yeastlike fungi
Staib, F. (1966) · Medical Mycology · doi:10.1080/00362176685190421 · Cited by 228 · see citing works
Xiang, M.-J., Liu, J.-Y., Ni, P.-H., Wang, S., Shi, C., Wei, B., Ni, Y.-X., & Ge, H.-L. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12042 · Cited by 197 · see citing works
Fluconazole-Resistant Candida albicans Vulvovaginitis
Marchaim, D., Lemanek, L., Bheemreddy, S., Kaye, K. S., & Sobel, J. D. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31827307b2 · Cited by 195 · see citing works
Kantarcioǧlu, A. S., & Yücel, A. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00727.x · Cited by 170 · see citing works
Comparison of Different Methods for Extraction of Mitochondrial DNA from Human Pathogenic Yeasts
Yamada, Y., Makimura, K., Mirhendi, H., Ueda, K., Nishiyama, Y., Yamaguchi, H., & Osumi, M. (2002) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2002.122 · Cited by 133 · see citing works
Vermitsky, J., Self, M. J., Chadwick, S. G., Trama, J. P., Adelson, M. E., Mordechai, E., & Gygax, S. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02485-07 · Cited by 123 · see citing works
Xu, Y., Chen, L., & Li, C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn015 · Cited by 104 · see citing works
Gokce, G., Çerikçioğlu, N., & Yağcı, A. (2007) · Mycopathologia · doi:10.1007/s11046-007-9053-4 · Cited by 96 · see citing works
Samaranayake, Y. H., Dassanayake, R. S., Jayatilake, J. A. M. S., Cheung, B., Yau, J. Y. Y., Yeung, K. W. S., & Samaranayake, L. P. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45762-0 · Cited by 78 · see citing works
Vulvovaginal candidiasis: Etiology, symptomatology and risk factors
Mtibaa, L., Fakhfakh, N., Kallel, A., Belhadj, S., Salah, N. B., Bada, N., & Kallel, K. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.01.003 · Cited by 74 · see citing works
Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia
Amouri, I., Sellami, H., Borji, N., Abbes, S., Sellami, A., Cheikhrouhou, F., Maazoun, L., Khaled, S., Khrouf, S., Boujelben, Y., et al. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01965.x · Cited by 72 · see citing works
Identification of Mycoses in Developing Countries
Arastehfar, A. A., Wickes, B. L., İlkit, M., Pincus, D., Daneshnia, F., Pan, W., Fang, W., & Boekhout, T. (2019) · Journal of Fungi · doi:10.3390/jof5040090 · Cited by 63 · see citing works
Maraki, S., Mavromanolaki, V. E., Stafylaki, D., Nioti, E., Hamilos, G., & Kasimati, A. (2019) · Mycoses · doi:10.1111/myc.12946 · Cited by 57 · see citing works
Dabiri, S., Shams‐Ghahfarokhi, M., & Razzaghi‐Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.04.009 · Cited by 56 · see citing works
Self-citationZhang, J., Liu, J., Liu, F., Xia, Y., Wang, J., Xi, L., Zhang, Z., Zhu, N., Yanyan, Ying, Y., et al. (2014) · Mycoses · doi:10.1111/myc.12204 · Cited by 50 · see citing works
Changing Trends of Vulvovaginal Candidiasis
Vijaya, D., Dhanalakshmi, T. A., & Kulkarni, S. R. (2014) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.129087 · Cited by 47 · see citing works
Arastehfar, A. A., Kargar, M. L., Mohammadi, S. R., Roudbary, M., Ghods, N., Haghighi, L., Daneshnia, F., Tavakoli, M., Jafarzadeh, J., Hedayati, M. T., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.655069 · Cited by 42 · see citing works
Wang, B., Huang, L., Zhao, J., Wei, M., Fang, H., Wang, D., Wang, H.-F., Yin, J., & Mei, X. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2015.08.002 · Cited by 37 · see citing works
Sarıgüzel, F. M., Berk, E., Koç, A. N., et al. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.5359 · Cited by 37 · see citing works
Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018)
Arastehfar, A. A., Yazdanpanah, S., Bakhtiari, M., Fang, W., Pan, W., Mahmoudi, S., Pakshir, K., Daneshnia, F., Boekhout, T., İlkit, M., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa059 · Cited by 33 · see citing works
Fattouh, N., Hdayed, D., Geukgeuzian, G., Tokajian, S. T., & Khalaf, R. A. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103575 · Cited by 30 · see citing works
EVALUATION OF DIFFERENT MEDIA FOR GERM TUBE PRODUCTION OF CANDIDA ALBICANS AND CANDIDA DUBLINIENSIS
Deorukhkar, S. C., Saini, S., & Jadhav, P. A. (2012) · International Journal of Biomedical and Advance Research · doi:10.7439/ijbar.v3i9.732 · Cited by 26 · see citing works
Phospholipase and proteinase activities of Candida spp. isolates from vulvovaginitis in Iran
Shirkhani, S., Sepahvand, A., Mirzaee, M., et al. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.05.001 · Cited by 26 · see citing works
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
Woodburn, K. W., Clemens, L. E., Jaynes, J., Joubert, L.-M., Botha, A., Nazik, H., & Stevens, D. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02690-18 · Cited by 25 · see citing works
Kalkancı, A., Güzel, A. B., Jabban, I. I. K., Aydın, M., İlkit, M., & Kuştımur, S. (2013) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2013.767323 · Cited by 24 · see citing works
Burden of fungal infections in Iran
Hedayati, M. T., Armaki, M. T., Charati, J. Y., Hedayati, N., Seyedmousavi, S., & Denning, D. W. (2018) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.10476 · Cited by 24 · see citing works
Sitterlé, E., Coste, A. T., Obadia, T., Maufrais, C., Chauvel, M., Sertour, N., Sanglard, D., Puel, A., d’Enfert, C., & Bougnoux, M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz537 · Cited by 23 · see citing works
Zhang, L., Yang, H., Liu, Y., Xu, X.-H., Ye, Y., & Li, J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.08.018 · Cited by 22 · see citing works
Wu, Y., Li, C., Wang, Z., Gao, J. Q., Tang, Z., Chen, H., & Ying, C. (2017) · Medical Mycology · doi:10.1093/mmy/myx099 · Cited by 19 · see citing works
Pfaller, M. A., Castanheira, M., Lockhart, S. R., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0091-0 · Cited by 17 · see citing works
Apport du milieu chromogène CHROMagar® Candida dans le diagnostic mycologique des levures
Ouanes, A., Kouais, A., Marouen, S., Sahnoun, M., Jemli, B., & Gargouri, S. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.07.058 · Cited by 15 · see citing works
Comparison of Chromogenic Media with the Corn Meal Agar for Speciation of Candida
Bharathi, R. (2018) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.12.3.68 · Cited by 12 · see citing works
Association of T916C (Y257H) mutation inCandida albicans ERG11with fluconazole resistance
Zhao, J., Xu, Y., & Li, C. (2012) · Mycoses · doi:10.1111/myc.12027 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7 · see citing works
“Moreover, mutations in the ERG11 gene reduce the affinity of Erg11p for fluconazole, complicating the treatment of candidiasis [47, 48].”
Zhu, X., Jin, F., Yang, G., Zhuang, T., Zhang, C., Zhou, H., Niu, X., Wang, H., & Wu, D. (2024) · Journal of Fungi · doi:10.3390/jof10060391 · Cited by 5 · see citing works
- Authors
- Esfahani, A., Omran, A. N., Salehi, Z., Shams-Ghahfarokhi, M., Ghane, M., Eybpoosh, S., & Razzaghi-Abyaneh, M.
- Affiliations
- Islamic Azad University Tonekabon (IR)
- Pasteur Institute of Iran (IR)
- Corresponding author
- Omran, Ayatollah Nasrollahi
- Venue
- Microbial Pathogenesis
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 170
- Pages
- 105696
- ISSN
- 0882-4010 (ISSN-L)
- OpenAlex
- W4289079912
- Cited by
- 30
- References
- 45
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 7 · 2023: 6
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 337 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Microbial Pathogenesis (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Medical Research Development
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- vaginal candidiasis, recurrent vulvovaginal candidiasis, Candida albicans, ERG11, fluconazole resistance, antifungal susceptibility, ergosterol, virulence factors, phospholipase, proteolytic enzymes, Candida glabrata, Candida tropicalis, Candida krusei, Candida parapsilosis, Candida guilliermondii, ketoconazole, molecular epidemiology
- MeSH terms
- Candida parapsilosis, Antifungal Agents, Candida, Candida albicans, Candidiasis, Vulvovaginal, Ergosterol, Female, Fungal Proteins, Humans, Microbial Sensitivity Tests, Mutation, Peptide Hydrolases, Phospholipases, Fluconazole, Molecular Epidemiology, Drug Resistance, Fungal, Candida tropicalis, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review